MIRADOR Trademark

Trademark Overview


On Thursday, November 9, 2023, a trademark application was filed for MIRADOR with the United States Patent and Trademark Office. The USPTO has given the MIRADOR trademark a serial number of 98262767. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 1, 2024. This trademark is owned by Mirador Therapeutics, Inc.. The MIRADOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents
mirador

General Information


Serial Number98262767
Word MarkMIRADOR
Filing DateThursday, November 9, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents
Translation of Words in MarkThe English translation of "MIRADOR" in the mark is "vantage point".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMirador Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirador Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, December 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 13, 2023NEW APPLICATION ENTERED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Tuesday, June 18, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024NON-FINAL ACTION WRITTEN
Saturday, August 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, August 24, 2024EXAMINERS AMENDMENT -WRITTEN
Saturday, August 24, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, August 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED